Home > Income Statement > NGL FINECHEM

NGL FINECHEM
Revenue

    Back to Income Statement
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹339 Cr₹278 Cr₹318 Cr₹258 Cr₹15,168,639 Cr

What is the latest Revenue of NGL FINECHEM ?

The latest Revenue ratio of NGL FINECHEM is ₹339 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹339 Cr
Mar2024₹278 Cr
Mar2023₹318 Cr
Mar2022₹258 Cr
Mar2021₹15,168,639 Cr

How is Revenue of NGL FINECHEM Trending?

Years Revenue % Change
Mar2025 ₹339 Cr
21.79
Mar2024 ₹278 Cr
-12.42
Mar2023 ₹318 Cr
23.08
Mar2022 ₹258 Cr
-100.00
Mar2021 ₹15,168,639 Cr -

Compare Revenue of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹918.7 Cr 6.6% 14.5% -15.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,631.0 Cr 1.9% -0.8% -3.5% Stock Analytics
DIVIS LABORATORIES ₹175,111.0 Cr 3.2% 4.8% 12.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,228.0 Cr 6.3% 8.9% 15.8% Stock Analytics
CIPLA ₹117,983.0 Cr -3.3% -2% -1.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,782.0 Cr -3.8% -3.1% -8% Stock Analytics


NGL FINECHEM Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

6.6%

14.5%

-15.8%

SENSEX

-1.2%

-1.1%

6.3%


You may also like the below Video Courses